Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Portfolio Pulse from
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) will participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on March 5, 2025. The company focuses on developing therapeutics using its INTASYL® siRNA gene silencing technology to enhance immune cell effectiveness against cancer.
February 26, 2025 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phio Pharmaceuticals is set to participate in a virtual roadshow, highlighting its INTASYL® siRNA technology aimed at improving cancer treatment. This event could increase investor interest and visibility for the company.
The participation in the roadshow provides Phio Pharmaceuticals with a platform to showcase its innovative technology, potentially attracting new investors and increasing market visibility. This could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100